APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mebendazole

Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.

Selected research

Market Analysis & Forecast

Global Mebendazole Market Analysis and Forecast 2026-2032

28 December 2025191 pages

Choose your research edition.

Industry ResearchMebendazole Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Mebendazole Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Mebendazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mebendazole Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Mebendazole Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.

The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.

Mebendazole is widely used for <2 Years Old and >=2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.

Read the full market overview

Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.

This report presents an overview of global market for Mebendazole, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Mebendazole, also provides the sales of main regions and countries. Of the upcoming market potential for Mebendazole, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Mebendazole sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Mebendazole market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Mebendazole sales, projected growth trends, production technology, application and end-user industry.

Mebendazole Segment by Company

Johnson & Johnson

Amneal Pharmaceuticals

Cadila Pharmaceuticals

Eipico

Esteve Pharmaceuticals

Tenry

Mebendazole Segment by Type

Tablet

Oral Suspension

Mebendazole Segment by Application

Below 2 Years Old

Above 2 Years Old

Mebendazole Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mebendazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mebendazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mebendazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Mebendazole in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Mebendazole manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mebendazole sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mebendazole Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablet Major Manufacturers Table 3. Oral Suspension Major Manufacturers Table 4. Global Mebendazole Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Below 2 Years Old Major Manufacturers Table 6. Above 2 Years Old Major Manufacturers Table 7. Mebendazole Industry Trends Table 8. Mebendazole Industry Drivers Table 9. Mebendazole Industry Opportunities and Challenges Table 10. Mebendazole Industry Restraints Table 11. Global Mebendazole Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Mebendazole Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Mebendazole Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Mebendazole Revenue Market Share by Region (2021-2026) Table 15. Global Mebendazole Revenue Market Share by Region (2027-2032) Table 16. Global Mebendazole Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Mebendazole Sales by Region (2021-2026) & (K Units) Table 18. Global Mebendazole Sales by Region (2027-2032) & (K Units) Table 19. Global Mebendazole Sales Market Share by Region (2021-2026) Table 20. Global Mebendazole Sales Market Share by Region (2027-2032) Table 21. Global Mebendazole Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Mebendazole Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Mebendazole Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Mebendazole Sales Market Share by Manufacturers (2021-2026) Table 25. Global Mebendazole Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 26. Global Mebendazole Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Mebendazole Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Mebendazole Manufacturers, Product Type & Application Table 29. Global Mebendazole Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Mebendazole by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Mebendazole Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Mebendazole Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Mebendazole Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Mebendazole Revenue Market Share by Type (2021-2026) Table 36. Global Mebendazole Revenue Market Share by Type (2027-2032) Table 37. Global Mebendazole Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Mebendazole Sales by Type (2021-2026) & (K Units) Table 39. Global Mebendazole Sales by Type (2027-2032) & (K Units) Table 40. Global Mebendazole Sales Market Share by Type (2021-2026) Table 41. Global Mebendazole Sales Market Share by Type (2027-2032) Table 42. Global Mebendazole Price by Type (2021-2026) & (USD/Unit) Table 43. Global Mebendazole Price by Type (2027-2032) & (USD/Unit) Table 44. Global Mebendazole Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Mebendazole Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Mebendazole Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Mebendazole Revenue Market Share by Application (2021-2026) Table 48. Global Mebendazole Revenue Market Share by Application (2027-2032) Table 49. Global Mebendazole Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Mebendazole Sales by Application (2021-2026) & (K Units) Table 51. Global Mebendazole Sales by Application (2027-2032) & (K Units) Table 52. Global Mebendazole Sales Market Share by Application (2021-2026) Table 53. Global Mebendazole Sales Market Share by Application (2027-2032) Table 54. Global Mebendazole Price by Application (2021-2026) & (USD/Unit) Table 55. Global Mebendazole Price by Application (2027-2032) & (USD/Unit) Table 56. Johnson & Johnson Company Information Table 57. Johnson & Johnson Business Overview Table 58. Johnson & Johnson Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 59. Johnson & Johnson Mebendazole Product Portfolio Table 60. Johnson & Johnson Recent Development Table 61. Amneal Pharmaceuticals Company Information Table 62. Amneal Pharmaceuticals Business Overview Table 63. Amneal Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 64. Amneal Pharmaceuticals Mebendazole Product Portfolio Table 65. Amneal Pharmaceuticals Recent Development Table 66. Cadila Pharmaceuticals Company Information Table 67. Cadila Pharmaceuticals Business Overview Table 68. Cadila Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. Cadila Pharmaceuticals Mebendazole Product Portfolio Table 70. Cadila Pharmaceuticals Recent Development Table 71. Eipico Company Information Table 72. Eipico Business Overview Table 73. Eipico Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Eipico Mebendazole Product Portfolio Table 75. Eipico Recent Development Table 76. Esteve Pharmaceuticals Company Information Table 77. Esteve Pharmaceuticals Business Overview Table 78. Esteve Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Esteve Pharmaceuticals Mebendazole Product Portfolio Table 80. Esteve Pharmaceuticals Recent Development Table 81. Tenry Company Information Table 82. Tenry Business Overview Table 83. Tenry Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Tenry Mebendazole Product Portfolio Table 85. Tenry Recent Development Table 86. North America Mebendazole Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Mebendazole Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Mebendazole Sales by Type (2021-2026) & (K Units) Table 89. North America Mebendazole Sales by Type (2027-2032) & (K Units) Table 90. North America Mebendazole Sales Price by Type (2021-2026) & (USD/Unit) Table 91. North America Mebendazole Sales Price by Type (2027-2032) & (USD/Unit) Table 92. North America Mebendazole Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Mebendazole Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Mebendazole Sales by Application (2021-2026) & (K Units) Table 95. North America Mebendazole Sales by Application (2027-2032) & (K Units) Table 96. North America Mebendazole Sales Price by Application (2021-2026) & (USD/Unit) Table 97. North America Mebendazole Sales Price by Application (2027-2032) & (USD/Unit) Table 98. North America Mebendazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Mebendazole Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. North America Mebendazole Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. North America Mebendazole Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 102. North America Mebendazole Sales by Country (2021-2026) & (K Units) Table 103. North America Mebendazole Sales by Country (2027-2032) & (K Units) Table 104. North America Mebendazole Sales Price by Country (2021-2026) & (USD/Unit) Table 105. North America Mebendazole Sales Price by Country (2027-2032) & (USD/Unit) Table 106. United States Mebendazole Revenue (2021-2032) & (US$ Million) Table 107. Canada Mebendazole Revenue (2021-2032) & (US$ Million) Table 108. Mexico Mebendazole Revenue (2021-2032) & (US$ Million) Table 109. Europe Mebendazole Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Mebendazole Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Mebendazole Sales by Type (2021-2026) & (K Units) Table 112. Europe Mebendazole Sales by Type (2027-2032) & (K Units) Table 113. Europe Mebendazole Sales Price by Type (2021-2026) & (USD/Unit) Table 114. Europe Mebendazole Sales Price by Type (2027-2032) & (USD/Unit) Table 115. Europe Mebendazole Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Mebendazole Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Mebendazole Sales by Application (2021-2026) & (K Units) Table 118. Europe Mebendazole Sales by Application (2027-2032) & (K Units) Table 119. Europe Mebendazole Sales Price by Application (2021-2026) & (USD/Unit) Table 120. Europe Mebendazole Sales Price by Application (2027-2032) & (USD/Unit) Table 121. Europe Mebendazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Mebendazole Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Mebendazole Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Mebendazole Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. Europe Mebendazole Sales by Country (2021-2026) & (K Units) Table 126. Europe Mebendazole Sales by Country (2027-2032) & (K Units) Table 127. Europe Mebendazole Sales Price by Country (2021-2026) & (USD/Unit) Table 128. Europe Mebendazole Sales Price by Country (2027-2032) & (USD/Unit) Table 129. Germany Mebendazole Revenue (2021-2032) & (US$ Million) Table 130. France Mebendazole Revenue (2021-2032) & (US$ Million) Table 131. U.K. Mebendazole Revenue (2021-2032) & (US$ Million) Table 132. Italy Mebendazole Revenue (2021-2032) & (US$ Million) Table 133. Russia Mebendazole Revenue (2021-2032) & (US$ Million) Table 134. Spain Mebendazole Revenue (2021-2032) & (US$ Million) Table 135. Netherlands Mebendazole Revenue (2021-2032) & (US$ Million) Table 136. Switzerland Mebendazole Revenue (2021-2032) & (US$ Million) Table 137. Sweden Mebendazole Revenue (2021-2032) & (US$ Million) Table 138. Poland Mebendazole Revenue (2021-2032) & (US$ Million) Table 139. China Mebendazole Revenue by Type (2021-2026) & (US$ Million) Table 140. China Mebendazole Revenue by Type (2027-2032) & (US$ Million) Table 141. China Mebendazole Sales by Type (2021-2026) & (K Units) Table 142. China Mebendazole Sales by Type (2027-2032) & (K Units) Table 143. China Mebendazole Sales Price by Type (2021-2026) & (USD/Unit) Table 144. China Mebendazole Sales Price by Type (2027-2032) & (USD/Unit) Table 145. China Mebendazole Revenue by Application (2021-2026) & (US$ Million) Table 146. China Mebendazole Revenue by Application (2027-2032) & (US$ Million) Table 147. China Mebendazole Sales by Application (2021-2026) & (K Units) Table 148. China Mebendazole Sales by Application (2027-2032) & (K Units) Table 149. China Mebendazole Sales Price by Application (2021-2026) & (USD/Unit) Table 150. China Mebendazole Sales Price by Application (2027-2032) & (USD/Unit) Table 151. Asia Mebendazole Revenue by Type (2021-2026) & (US$ Million) Table 152. Asia Mebendazole Revenue by Type (2027-2032) & (US$ Million) Table 153. Asia Mebendazole Sales by Type (2021-2026) & (K Units) Table 154. Asia Mebendazole Sales by Type (2027-2032) & (K Units) Table 155. Asia Mebendazole Sales Price by Type (2021-2026) & (USD/Unit) Table 156. Asia Mebendazole Sales Price by Type (2027-2032) & (USD/Unit) Table 157. Asia Mebendazole Revenue by Application (2021-2026) & (US$ Million) Table 158. Asia Mebendazole Revenue by Application (2027-2032) & (US$ Million) Table 159. Asia Mebendazole Sales by Application (2021-2026) & (K Units) Table 160. Asia Mebendazole Sales by Application (2027-2032) & (K Units) Table 161. Asia Mebendazole Sales Price by Application (2021-2026) & (USD/Unit) Table 162. Asia Mebendazole Sales Price by Application (2027-2032) & (USD/Unit) Table 163. Asia Mebendazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Asia Mebendazole Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. Asia Mebendazole Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. Asia Mebendazole Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 167. Asia Mebendazole Sales by Country (2021-2026) & (K Units) Table 168. Asia Mebendazole Sales by Country (2027-2032) & (K Units) Table 169. Asia Mebendazole Sales Price by Country (2021-2026) & (USD/Unit) Table 170. Asia Mebendazole Sales Price by Country (2027-2032) & (USD/Unit) Table 171. Japan Mebendazole Revenue (2021-2032) & (US$ Million) Table 172. South Korea Mebendazole Revenue (2021-2032) & (US$ Million) Table 173. India Mebendazole Revenue (2021-2032) & (US$ Million) Table 174. Australia Mebendazole Revenue (2021-2032) & (US$ Million) Table 175. Taiwan Mebendazole Revenue (2021-2032) & (US$ Million) Table 176. Southeast Asia Mebendazole Revenue (2021-2032) & (US$ Million) Table 177. SAMEA Mebendazole Revenue by Type (2021-2026) & (US$ Million) Table 178. SAMEA Mebendazole Revenue by Type (2027-2032) & (US$ Million) Table 179. SAMEA Mebendazole Sales by Type (2021-2026) & (K Units) Table 180. SAMEA Mebendazole Sales by Type (2027-2032) & (K Units) Table 181. SAMEA Mebendazole Sales Price by Type (2021-2026) & (USD/Unit) Table 182. SAMEA Mebendazole Sales Price by Type (2027-2032) & (USD/Unit) Table 183. SAMEA Mebendazole Revenue by Application (2021-2026) & (US$ Million) Table 184. SAMEA Mebendazole Revenue by Application (2027-2032) & (US$ Million) Table 185. SAMEA Mebendazole Sales by Application (2021-2026) & (K Units) Table 186. SAMEA Mebendazole Sales by Application (2027-2032) & (K Units) Table 187. SAMEA Mebendazole Sales Price by Application (2021-2026) & (USD/Unit) Table 188. SAMEA Mebendazole Sales Price by Application (2027-2032) & (USD/Unit) Table 189. SAMEA Mebendazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. SAMEA Mebendazole Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. SAMEA Mebendazole Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. SAMEA Mebendazole Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 193. SAMEA Mebendazole Sales by Country (2021-2026) & (K Units) Table 194. SAMEA Mebendazole Sales by Country (2027-2032) & (K Units) Table 195. SAMEA Mebendazole Sales Price by Country (2021-2026) & (USD/Unit) Table 196. SAMEA Mebendazole Sales Price by Country (2027-2032) & (USD/Unit) Table 197. Brazil Mebendazole Revenue (2021-2032) & (US$ Million) Table 198. Argentina Mebendazole Revenue (2021-2032) & (US$ Million) Table 199. Chile Mebendazole Revenue (2021-2032) & (US$ Million) Table 200. Colombia Mebendazole Revenue (2021-2032) & (US$ Million) Table 201. Peru Mebendazole Revenue (2021-2032) & (US$ Million) Table 202. Saudi Arabia Mebendazole Revenue (2021-2032) & (US$ Million) Table 203. Israel Mebendazole Revenue (2021-2032) & (US$ Million) Table 204. UAE Mebendazole Revenue (2021-2032) & (US$ Million) Table 205. Turkey Mebendazole Revenue (2021-2032) & (US$ Million) Table 206. Iran Mebendazole Revenue (2021-2032) & (US$ Million) Table 207. Egypt Mebendazole Revenue (2021-2032) & (US$ Million) Table 208. Key Raw Materials Table 209. Raw Materials Key Suppliers Table 210. Mebendazole Distributors List Table 211. Mebendazole Customers List Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. Mebendazole Image Figure 2. Global Mebendazole Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mebendazole Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablet Image Figure 5. Oral Suspension Image Figure 6. Global Mebendazole Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Mebendazole Market Size Share 2021 VS 2025 VS 2032 Figure 8. Below 2 Years Old Image Figure 9. Above 2 Years Old Image Figure 10. Global Mebendazole Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Mebendazole Revenue (2021-2032) & (US$ Million) Figure 12. Global Mebendazole Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Mebendazole Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Mebendazole Revenue Market Share by Region (2021-2032) Figure 15. Global Mebendazole Sales (2021-2032) & (K Units) Figure 16. Global Mebendazole Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Mebendazole Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Mebendazole Sales YoY (2021-2032) & (K Units) Figure 19. Europe Mebendazole Sales YoY (2021-2032) & (K Units) Figure 20. China Mebendazole Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Mebendazole Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Mebendazole Sales YoY (2021-2032) & (K Units) Figure 23. Global Mebendazole Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Mebendazole Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Mebendazole Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Mebendazole Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Mebendazole Revenue Market Share by Type (2021-2032) Figure 29. Global Mebendazole Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Mebendazole Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Mebendazole Sales Market Share by Type (2021-2032) Figure 32. Global Mebendazole Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Mebendazole Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Mebendazole Revenue Market Share by Application (2021-2032) Figure 35. Global Mebendazole Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Mebendazole Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Mebendazole Sales Market Share by Application (2021-2032) Figure 38. North America Mebendazole Revenue Share by Type (2021-2032) Figure 39. North America Mebendazole Sales Share by Type (2021-2032) Figure 40. North America Mebendazole Revenue Share by Application (2021-2032) Figure 41. North America Mebendazole Sales Share by Application (2021-2032) Figure 42. North America Mebendazole Revenue Share by Country (2021-2032) Figure 43. North America Mebendazole Sales Share by Country (2021-2032) Figure 44. Europe Mebendazole Revenue Share by Type (2021-2032) Figure 45. Europe Mebendazole Sales Share by Type (2021-2032) Figure 46. Europe Mebendazole Revenue Share by Application (2021-2032) Figure 47. Europe Mebendazole Sales Share by Application (2021-2032) Figure 48. Europe Mebendazole Revenue Share by Country (2021-2032) Figure 49. Europe Mebendazole Sales Share by Country (2021-2032) Figure 50. China Mebendazole Revenue Share by Type (2021-2032) Figure 51. China Mebendazole Sales Share by Type (2021-2032) Figure 52. China Mebendazole Revenue Share by Application (2021-2032) Figure 53. China Mebendazole Sales Share by Application (2021-2032) Figure 54. Asia Mebendazole Revenue Share by Type (2021-2032) Figure 55. Asia Mebendazole Sales Share by Type (2021-2032) Figure 56. Asia Mebendazole Revenue Share by Application (2021-2032) Figure 57. Asia Mebendazole Sales Share by Application (2021-2032) Figure 58. Asia Mebendazole Revenue Share by Country (2021-2032) Figure 59. Asia Mebendazole Sales Share by Country (2021-2032) Figure 60. SAMEA Mebendazole Revenue Share by Type (2021-2032) Figure 61. SAMEA Mebendazole Sales Share by Type (2021-2032) Figure 62. SAMEA Mebendazole Revenue Share by Application (2021-2032) Figure 63. SAMEA Mebendazole Sales Share by Application (2021-2032) Figure 64. SAMEA Mebendazole Revenue Share by Country (2021-2032) Figure 65. SAMEA Mebendazole Sales Share by Country (2021-2032) Figure 66. Mebendazole Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Mebendazole Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Oral Suspension
Applications
  • Below 2 Years Old
  • Above 2 Years Old
Companies covered
  • Johnson & Johnson
  • Amneal Pharmaceuticals
  • Cadila Pharmaceuticals
  • Eipico
  • Esteve Pharmaceuticals
  • Tenry

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Mebendazole Market by Type
  3. 1.2.1 Global Mebendazole Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablet
  5. 1.2.3 Oral Suspension
  6. 1.3 Mebendazole Market by Application
  7. 1.3.1 Global Mebendazole Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Below 2 Years Old
  9. 1.3.3 Above 2 Years Old
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Mebendazole Market Dynamics
  1. 2.1 Mebendazole Industry Trends
  2. 2.2 Mebendazole Industry Drivers
  3. 2.3 Mebendazole Industry Opportunities and Challenges
  4. 2.4 Mebendazole Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Mebendazole Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Mebendazole Revenue by Region
  3. 3.2.1 Global Mebendazole Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Mebendazole Revenue by Region (2021-2026)
  5. 3.2.3 Global Mebendazole Revenue by Region (2027-2032)
  6. 3.2.4 Global Mebendazole Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Mebendazole Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Mebendazole Sales by Region
  9. 3.4.1 Global Mebendazole Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Mebendazole Sales by Region (2021-2026)
  11. 3.4.3 Global Mebendazole Sales by Region (2027-2032)
  12. 3.4.4 Global Mebendazole Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Mebendazole Revenue by Manufacturers
  2. 4.1.1 Global Mebendazole Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Mebendazole Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Mebendazole Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Mebendazole Sales by Manufacturers
  6. 4.2.1 Global Mebendazole Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Mebendazole Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Mebendazole Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Mebendazole Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Mebendazole Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Mebendazole Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Mebendazole Manufacturers, Product Type & Application
  13. 4.7 Global Mebendazole Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Mebendazole Market CR5 and HHI
  16. 4.8.2 2025 Mebendazole Tier 1, Tier 2, and Tier 3
5 Mebendazole Market by Type
  1. 5.1 Global Mebendazole Revenue by Type
  2. 5.1.1 Global Mebendazole Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Mebendazole Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Mebendazole Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Mebendazole Sales by Type
  6. 5.2.1 Global Mebendazole Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mebendazole Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Mebendazole Sales Market Share by Type (2021-2032)
  9. 5.3 Global Mebendazole Price by Type
6 Mebendazole Market by Application
  1. 6.1 Global Mebendazole Revenue by Application
  2. 6.1.1 Global Mebendazole Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Mebendazole Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Mebendazole Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Mebendazole Sales by Application
  6. 6.2.1 Global Mebendazole Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Mebendazole Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Mebendazole Sales Market Share by Application (2021-2032)
  9. 6.3 Global Mebendazole Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Mebendazole Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Mebendazole Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Amneal Pharmaceuticals
  8. 7.2.1 Amneal Pharmaceuticals Company Information
  9. 7.2.2 Amneal Pharmaceuticals Business Overview
  10. 7.2.3 Amneal Pharmaceuticals Mebendazole Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Amneal Pharmaceuticals Mebendazole Product Portfolio
  12. 7.2.5 Amneal Pharmaceuticals Recent Developments
  13. 7.3 Cadila Pharmaceuticals
  14. 7.3.1 Cadila Pharmaceuticals Company Information
  15. 7.3.2 Cadila Pharmaceuticals Business Overview
  16. 7.3.3 Cadila Pharmaceuticals Mebendazole Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Cadila Pharmaceuticals Mebendazole Product Portfolio
  18. 7.3.5 Cadila Pharmaceuticals Recent Developments
  19. 7.4 Eipico
  20. 7.4.1 Eipico Company Information
  21. 7.4.2 Eipico Business Overview
  22. 7.4.3 Eipico Mebendazole Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Eipico Mebendazole Product Portfolio
  24. 7.4.5 Eipico Recent Developments
  25. 7.5 Esteve Pharmaceuticals
  26. 7.5.1 Esteve Pharmaceuticals Company Information
  27. 7.5.2 Esteve Pharmaceuticals Business Overview
  28. 7.5.3 Esteve Pharmaceuticals Mebendazole Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Esteve Pharmaceuticals Mebendazole Product Portfolio
  30. 7.5.5 Esteve Pharmaceuticals Recent Developments
  31. 7.6 Tenry
  32. 7.6.1 Tenry Company Information
  33. 7.6.2 Tenry Business Overview
  34. 7.6.3 Tenry Mebendazole Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Tenry Mebendazole Product Portfolio
  36. 7.6.5 Tenry Recent Developments
8 North America
  1. 8.1 North America Mebendazole Market Size by Type
  2. 8.1.1 North America Mebendazole Revenue by Type (2021-2032)
  3. 8.1.2 North America Mebendazole Sales by Type (2021-2032)
  4. 8.1.3 North America Mebendazole Price by Type (2021-2032)
  5. 8.2 North America Mebendazole Market Size by Application
  6. 8.2.1 North America Mebendazole Revenue by Application (2021-2032)
  7. 8.2.2 North America Mebendazole Sales by Application (2021-2032)
  8. 8.2.3 North America Mebendazole Price by Application (2021-2032)
  9. 8.3 North America Mebendazole Market Size by Country
  10. 8.3.1 North America Mebendazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Mebendazole Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Mebendazole Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Mebendazole Market Size by Type
  2. 9.1.1 Europe Mebendazole Revenue by Type (2021-2032)
  3. 9.1.2 Europe Mebendazole Sales by Type (2021-2032)
  4. 9.1.3 Europe Mebendazole Price by Type (2021-2032)
  5. 9.2 Europe Mebendazole Market Size by Application
  6. 9.2.1 Europe Mebendazole Revenue by Application (2021-2032)
  7. 9.2.2 Europe Mebendazole Sales by Application (2021-2032)
  8. 9.2.3 Europe Mebendazole Price by Application (2021-2032)
  9. 9.3 Europe Mebendazole Market Size by Country
  10. 9.3.1 Europe Mebendazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Mebendazole Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Mebendazole Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Mebendazole Market Size by Type
  2. 10.1.1 China Mebendazole Revenue by Type (2021-2032)
  3. 10.1.2 China Mebendazole Sales by Type (2021-2032)
  4. 10.1.3 China Mebendazole Price by Type (2021-2032)
  5. 10.2 China Mebendazole Market Size by Application
  6. 10.2.1 China Mebendazole Revenue by Application (2021-2032)
  7. 10.2.2 China Mebendazole Sales by Application (2021-2032)
  8. 10.2.3 China Mebendazole Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Mebendazole Market Size by Type
  2. 11.1.1 Asia Mebendazole Revenue by Type (2021-2032)
  3. 11.1.2 Asia Mebendazole Sales by Type (2021-2032)
  4. 11.1.3 Asia Mebendazole Price by Type (2021-2032)
  5. 11.2 Asia Mebendazole Market Size by Application
  6. 11.2.1 Asia Mebendazole Revenue by Application (2021-2032)
  7. 11.2.2 Asia Mebendazole Sales by Application (2021-2032)
  8. 11.2.3 Asia Mebendazole Price by Application (2021-2032)
  9. 11.3 Asia Mebendazole Market Size by Country
  10. 11.3.1 Asia Mebendazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Mebendazole Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Mebendazole Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Mebendazole Market Size by Type
  2. 12.1.1 SAMEA Mebendazole Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Mebendazole Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Mebendazole Price by Type (2021-2032)
  5. 12.2 SAMEA Mebendazole Market Size by Application
  6. 12.2.1 SAMEA Mebendazole Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Mebendazole Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Mebendazole Price by Application (2021-2032)
  9. 12.3 SAMEA Mebendazole Market Size by Country
  10. 12.3.1 SAMEA Mebendazole Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Mebendazole Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Mebendazole Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Mebendazole Value Chain Analysis
  2. 13.1.1 Mebendazole Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Mebendazole Production Mode & Process
  6. 13.2 Mebendazole Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Mebendazole Distributors
  9. 13.2.3 Mebendazole Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst